Watch out for MRK and PFE. Both could be suitors for ELN and BIIB as both have lots to lose from their cox 2 inhibitors.MRK would struggle with its current market cap, but it needs the potential revenue the most. PFE can easily do the gobble of both with only a little short term dilution. IMO, both are now in play.
I could see either taking both ELN & BIIBbottom line buy as much as you can stay away from margin.. and buy in the money calls if you want to leverage your position.JAN 06 Leaps strike price $20.00